Bipolar Disorder Clinical Trial
Official title:
The Roots of Metacognitive Failures in Bipolar Disorders: Clinical Determinants of the Discrepancy Between Objective and Subjective Cognition in the Versailles FACE-BD Cohort
Metacognitive abilities have been scarcely investigated in bipolar disorders, with
inconsistent results. This may appear somewhat surprising, as metacognitive training is a
very promising intervention aiming at improving psychosocial functioning in bipolar
disorders. One way to investigate metacognition is to address the discrepancy between
objectively measured cognition (through neuropsychological testing) and subjective cognition
(through self-reported questionnaire investigating one's perception of cognitive
functioning).
Objective and subjective cognition are two fundamental determinants of functioning in bipolar
disorder. Objectively-measured cognition is directly associated with performance-based
functional capacity but not with self-reported or interview-based functional capacity. In
contrast, subjectively-measured cognition is associated with self-reported and
interview-based functional capacity, but not performance-based functional capacity.
Associations between subjective cognitive functioning and neuropsychological performances are
usually weak, with a moderating effect of manic and depressive symptoms. Manic symptoms are
associated with a decrease in cognitive complains, whereas depressive symptoms are associated
with an increase in cognitive complaints. Predictors of the discrepancy between objective and
subjective cognition in bipolar disorder are still weakly understood. One study reported that
the subjective overestimation of cognitive dysfunctioning was positively predicted by more
subsyndromal depressive and manic symptoms, hospitalizations, and BD type II. This study also
reported that the subjective overestimation of cognitive dysfunctioning was associated with
greater socio-occupational difficulties, more perceived stress, and lower quality of life.
However, these previous studies had relatively limited sample sizes (below 150). They also
ignored other potential predictors of the discrepancy between objective and subjective
cognitions such as psychotic features, impulsiveness, and childhood trauma. Moreover, they
also ignored whether this discrepancy was associated with medication adherence.
The present study intends to explore the predictors of the discrepancy between objective and
subjective cognition in bipolar disorder in a cross-sectional sample of 387 stable
outpatients with bipolar disorders (type 1, type 2, not otherwise specified).
The second objective is to determine whether the discrepancy between objective and subjective
cognition in bipolar disorder predicts functioning, quality of life and medication adherence.
Metacognitive abilities have been scarcely investigated in bipolar disorders, with
inconsistent results. This may appear somewhat surprising, as metacognitive training is a
very promising intervention aiming at improving psychosocial functioning in bipolar
disorders. One way to investigate metacognition is to address the discrepancy between
objectively measured cognition (through neuropsychological testing) and subjective cognition
(through self-reported questionnaire investigating one's perception of cognitive
functioning).
Objective and subjective cognition are two fundamental determinants of functioning in bipolar
disorder. Objectively-measured cognition is directly associated with performance-based
functional capacity but not with self-reported or interview-based functional capacity. In
contrast, subjectively-measured cognition is associated with self-reported and
interview-based functional capacity, but not performance-based functional capacity.
Associations between subjective cognitive functioning and neuropsychological performances are
usually weak, with a moderating effect of manic and depressive symptoms. Manic symptoms are
associated with a decrease in cognitive complains, whereas depressive symptoms are associated
with an increase in cognitive complaints. Predictors of the discrepancy between objective and
subjective cognition in bipolar disorder are still weakly understood. One study reported that
the subjective overestimation of cognitive dysfunctioning was positively predicted by more
subsyndromal depressive and manic symptoms, hospitalizations, and BD type II. This study also
reported that the subjective overestimation of cognitive dysfunctioning was associated with
greater socio-occupational difficulties, more perceived stress, and lower quality of life.
However, these previous studies had relatively limited sample sizes (below 150). They also
ignored other potential predictors of the discrepancy between objective and subjective
cognitions such as psychotic features, impulsiveness, and childhood trauma. Moreover, they
also ignored whether this discrepancy was associated with medication adherence.
The present study intends to explore the predictors of the discrepancy between objective and
subjective cognition in bipolar disorder in a cross-sectional sample of 387 stable
outpatients with bipolar disorders (type 1, type 2, not otherwise specified). All
participants were included in the Versailles FACE-BD Cohort and were recruited via the
Versailles FondaMental Center of expertise for Bipolar Disorders. BD was diagnosed based on
the structured clinical interview that assesses DSM-IV-TR criteria.
Objective cognition was measured with a battery of cognitive tests. Experienced
neuropsychologists administered the tests in a fixed order that was the same for every
center. Testing lasted a total of 120 min, including 5 to 10-min breaks. The standardized
test battery complied with the recommendations issued by the International Society for
Bipolar Disorders. It included 11 tests and evaluated the following five cognitive domains:
- processing speed, using the digit symbol coding and symbol search subtests from the
Wechsler Adult Intelligence Scale (WAIS) version III, the Trail Making Test (TMT) part
A, and the word and the color conditions of the Stroop test
- attention, using the Conners' Continuous Performance Test II (omissions and commissions)
- executive functions, using the colour/word condition of the Stroop test, the TMT part B
and verbal fluency (semantic and phonemic conditions)
- verbal memory, using the California Verbal Learning Test (CVLT) immediate recall, short
and long delay free recall, and total recognition
- working memory, using the WAIS-III digit span (sum of forward and backward conditions)
and the spatial span (forward and backward conditions) subtest from the Wechsler Memory
Scale version III
Subjective cognition was measured with item 10 of the Quick Inventory of Depressive
Symptomatology-Self-Report-16.
This item focuses over the past 7 days and investigates "Concentration/decision-making:
- 0 There was no change in my usual ability to concentrate or make decisions.
- 1 I occasionally felt indecisive or found that my attention wandered.
- 2 Most of the time, I found it hard to focus or to make decisions.
- 3 I couldn't concentrate well enough to read or I couldn't make even minor decisions"
Predictors of the discrepancy between objective and subjective cognition were:
- type of bipolar disorder
- psychotic features
- age at onset; number of previous mixed, hypomanic, manic, and major depressive episodes;
total duration of hospitalizations
- severity of the bipolar disorder with the Clinical Global Impression-Severity
- lithium carbonate, anticonvulsants, antipsychotics, antidepressants, or anxiolytics at
the time of testing
- hetero-evaluation of depression with the Montgomery Åsberg Depression Rating Scale
- hetero-evaluation of mania with the Young Mania Rating Scale
- auto-evaluation of the state of anxiety with the state subscale of the State-Trait
Anxiety Inventory, form Y-A
- impulsiveness with the Barratt Impulsiveness Scale
- childhood trauma with the Childhood Trauma Questionnaire
The variable predicted by the discrepancy between objective and subjective cognition were:
- the global functioning with the Global Assessment of Functioning scale
- psychosocial functioning in everyday life was assessed with the Functioning Assessment
Short Test
- medication adherence with the MEDICATION ADHERENCE RATING SCALE
- quality of life with the EQ-5D
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT02855762 -
Targeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder
|
N/A | |
Recruiting |
NCT05915013 -
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
|
Phase 1 | |
Recruiting |
NCT05206747 -
Ottawa Sunglasses at Night for Mania Study
|
N/A | |
Completed |
NCT02513654 -
Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects
|
Phase 1 | |
Recruiting |
NCT06313918 -
Exercise Therapy in Mental Disorders-study
|
N/A | |
Completed |
NCT02304432 -
Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
|
Early Phase 1 | |
Recruiting |
NCT06197048 -
Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder
|
N/A | |
Completed |
NCT03497663 -
VIA Family - Family Based Early Intervention Versus Treatment as Usual
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Completed |
NCT02212041 -
Electronic Cigarettes in Smokers With Mental Illness
|
N/A | |
Recruiting |
NCT05030272 -
Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings
|
N/A | |
Recruiting |
NCT04298450 -
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention
|
N/A | |
Active, not recruiting |
NCT03641300 -
Efficacy of Convulsive Therapies for Bipolar Depression
|
N/A | |
Not yet recruiting |
NCT04432116 -
Time and Virtual Reality in Schizophrenia and Bipolar Disorder
|
N/A | |
Terminated |
NCT02893371 -
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
|
||
Terminated |
NCT02909504 -
Gao NARASD Lithium Study
|
Phase 4 | |
Completed |
NCT02970721 -
Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
|
||
Recruiting |
NCT02481245 -
BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study
|
Phase 2 | |
Recruiting |
NCT03088657 -
Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study
|